Literature DB >> 30117116

Understanding and Identifying Key Issues with the Involvement of Clinicians in the Development of Decision-Analytic Model Structures: A Qualitative Study.

Samantha Husbands1, Susan Jowett2, Pelham Barton2, Joanna Coast3.   

Abstract

INTRODUCTION: Decision-analytic models play an essential role in informing healthcare resource allocation decisions; however, their value to decision makers will depend on model structures being clinically valid to determine cost-effectiveness recommendations. Clinician involvement can help modellers to develop clinically valid but straightforward structures; however, there is little guidance available on methods for clinician input to model structure. This study aims to provide an in-depth exploration of clinician involvement in structural development, highlighting key issues and generating recommendations to optimise practices.
METHODS: A qualitative study was undertaken with a range of modellers and clinicians working in different modelling contexts. In-depth interviews and case studies using observations were carried out to understand how clinicians are involved in model structural development and to identify problems and optimal approaches from informants' perspectives.
RESULTS: Twenty-four interviews and two case studies were undertaken with modellers and modelling teams. Key issues included the number and diversity of clinicians contributing to structural development, potentially impacting the generalisability of structures, and problems with clinician understanding of important information to contribute to model pathways. Modellers and clinicians suggested that clinician training in modelling could enhance structural processes.
CONCLUSIONS: Recommendations to optimise current practices include recruiting clinicians from a variety of backgrounds and using discussions between experts to develop valid and generalisable structures. Future research should focus on developing training materials for clinicians and finding ways to help modellers recruit clinicians from different settings.

Mesh:

Year:  2018        PMID: 30117116     DOI: 10.1007/s40273-018-0705-7

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  19 in total

1.  Health economic evaluations using decision analytic modeling. Principles and practices--utilization of a checklist to their development and appraisal.

Authors:  Javier Soto
Journal:  Int J Technol Assess Health Care       Date:  2002       Impact factor: 2.188

Review 2.  Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application.

Authors:  M Sculpher; E Fenwick; K Claxton
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

Review 3.  Testing the validity of cost-effectiveness models.

Authors:  C McCabe; S Dixon
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

4.  Generalization in quantitative and qualitative research: myths and strategies.

Authors:  Denise F Polit; Cheryl Tatano Beck
Journal:  Int J Nurs Stud       Date:  2010-07-03       Impact factor: 5.837

Review 5.  Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment.

Authors:  Zoë Philips; Laura Bojke; Mark Sculpher; Karl Claxton; Su Golder
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

6.  Decision-analytical modelling in health-care economic evaluations.

Authors:  Xin Sun; Thomas Faunce
Journal:  Eur J Health Econ       Date:  2007-10-18

7.  Critically appraising qualitative research.

Authors:  Ayelet Kuper; Lorelei Lingard; Wendy Levinson
Journal:  BMJ       Date:  2008-08-07

Review 8.  A Systematic Review of Research Guidelines in Decision-Analytic Modeling.

Authors:  Maria Cristina Peñaloza Ramos; Pelham Barton; Sue Jowett; Andrew John Sutton
Journal:  Value Health       Date:  2015-02-07       Impact factor: 5.725

9.  Whither trial-based economic evaluation for health care decision making?

Authors:  Mark J Sculpher; Karl Claxton; Mike Drummond; Chris McCabe
Journal:  Health Econ       Date:  2006-07       Impact factor: 3.046

10.  Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic Evaluations.

Authors:  Cynthia P Iglesias; Alexander Thompson; Wolf H Rogowski; Katherine Payne
Journal:  Pharmacoeconomics       Date:  2016-11       Impact factor: 4.981

View more
  1 in total

1.  Health Economists on Involving Patients in Modeling: Potential Benefits, Harms, and Variables of Interest.

Authors:  Stephanie Harvard; Gregory R Werker
Journal:  Pharmacoeconomics       Date:  2021-05-07       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.